Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

July 31, 2026 07:00 ET | Source: Regeneron Pharmaceuticals, Inc.

Regeneron Awards $150,000 to Winners of the 2026 Regeneron Prize for Creative Innovation

Regeneron Awards $150,000 to Winners of the 2026 Regeneron Prize for Creative Innovation
July 31, 2026 06:46 ET | Source: Bleichmar Fonti & Auld

$REGN Securities: Suffer Losses on Your Regeneron Investment? BFA Law Reminds Investors of the Securities Fraud Lawsuit to Recover Losses

Suffer Losses on Your Regeneron Investment? BFA Law Reminds Investors of the Securities Fraud Lawsuit to Recover Losses
July 30, 2026 19:49 ET | Source: Hagens Berman Sobol Shapiro LLP

REGN ALERT: Hagens Berman Alerts Regeneron Pharmaceuticals, Inc. (REGN) Investors to Pending Securities Class Action Amid Disclosures About Key Trial’s Protocol and Ultimate Failure

Investors who lost money in REGN after its stock plunged due to allegedly misleading financial statements are urged to contact Hagens Berman.
July 29, 2026 06:17 ET | Source: Bleichmar Fonti & Auld

REGN Court Deadline: Regeneron Investor Deadline in Securities Fraud Class Action is September 14 – Contact BFA Law if You Lost Money

Regeneron Investor Deadline in Securities Fraud Class Action is September 14 – Contact BFA Law if You Lost Money
July 28, 2026 16:38 ET | Source: Hagens Berman Sobol Shapiro LLP

REGN ALERT: Hagens Berman Alerts Regeneron Pharmaceuticals, Inc. (REGN) Investors to Pending Securities Class Action Amid Disclosures About Key Trial’s Protocol and Ultimate Failure

Investors who lost money in REGN after its stock plunged due to allegedly misleading financial statements are urged to contact Hagens Berman.
July 27, 2026 09:38 ET | Source: Portnoy Law

Portnoy Law Firm Announces Class Action on Behalf of Regeneron Pharmaceuticals, Inc. Investors

LOS ANGELES, July 27, 2026 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Regeneron Pharmaceuticals, Inc., (“Regeneron” or the "Company") (NASDAQ: REGN) investors of a class action on behalf of...
July 27, 2026 07:36 ET | Source: Bleichmar Fonti & Auld

$REGN Lawsuit Notice: BFA Law Reminds Regeneron Investors of September 14 Lead Plaintiff Deadline After 9% Stock Drop Triggers Securities Fraud Class Action

BFA Law Reminds Regeneron Investors of September 14 Lead Plaintiff Deadline After 9% Stock Drop Triggers Securities Fraud Class Action
July 24, 2026 14:22 ET | Source: Hagens Berman Sobol Shapiro LLP

Regeneron Pharmaceuticals, Inc. (REGN) Faces Securities Class Action Amid Disclosures About Key Trial’s Protocol and Ultimate Failure - HBSS

Investors who lost money in REGN after its stock plunged due to allegedly misleading financial statements are urged to contact Hagens Berman.
July 24, 2026 10:31 ET | Source: Schall Law

REGN Investors Have Opportunity to Lead Regeneron Pharmaceuticals, Inc. Securities Fraud Lawsuit with the Schall Law Firm

REGN Investors Have Opportunity to Lead Regeneron Pharmaceuticals, Inc. Securities Fraud Lawsuit with the Schall Law Firm
July 24, 2026 06:36 ET | Source: Bleichmar Fonti & Auld

$REGN Fraud Notification: Regeneron Sued for Fraud Over Misrepresentations about its Clinical Trials – Investors Notified to Contact BFA Law

Regeneron Sued for Fraud Over Misrepresentations about its Clinical Trials – Investors Notified to Contact BFA Law